FEATURED NEWS

FDA
July 16, 2015
On December 19, the U.S. Food and Drug Administration approved Rapivab (peramivir) to treat influenza infection in adults. Influenza, commonly known as the flu, is a contagious respiratory illness caused by influenza viruses. Flu infections can range from mild to severe and can sometimes lead to hospitalization and death. According to the Centers for MORE
ACA
June 10, 2015
The Affordable Care Act made some major changes in the way individuals and families can access health insurance. This bi-weekly update throughout open enrollment is designed to provide information about health care changes for providers. While this is meant to highlight some important changes and updates, it is not an exhaustive list. 1. December 15th MORE
FDA
June 10, 2015
The U.S. Food and Drug Administration today approved Viekira Pak (ombitasvir, paritaprevir and ritonavir tablets co-packaged with dasabuvir tablets) to treat patients with chronic hepatitis C virus (HCV) genotype 1 infection, including those with a type of advanced liver disease called cirrhosis. Viekira Pak contains three new drugs-ombitasvir, MORE
FDA
June 10, 2015
On December 19, the U.S. Food and Drug Administration approved Rapivab (peramivir) to treat influenza infection in adults. Influenza, commonly known as the flu, is a contagious respiratory illness caused by influenza viruses. Flu infections can range from mild to severe and can sometimes lead to hospitalization and death. According to the Centers for MORE

Pages